"We're preparing for the next 100 years of innovation"
The Italian company Recordati's focus is to research and provide medicines for rare diseases as well as diseases in primary and specialist care. Their move to Hagastaden was a boost in every way.
"Joakim Åberg (General Manager RRD), Karin Möllerstedt (Finance Director), and Fredrik Sandström (General Manager SPC Nordic) with the lease agreement for Hagastaden."
Current news from Stockholm Science City
